Real World Data In Drug Marketing Applications: Drivers For Success
Applications Using RWD Were Approved Relatively Quickly
A study examining 27 drug marketing applications that contained real world data and an idea on how to make it easier for companies to understand which RWD to use were discussed this week at the RAPS EURO Convergence 2021 conference.
You may also be interested in...
The sponsor of what could become the EU’s first approved ophthalmic formulation of bevacizumab needs to address outstanding issues raised by the European Medicines Agency about its filing.
Janssen/Legend Biotech's ciltacabtagene autoleucel and Ipsen's palovarotene are among the latest new medicines that have been submitted for pan-EU approval.
The European Medicines Agency has added 13 new drugs to its list of products that are under review for potential pan-EU marketing approval.